News

Data centers' rapid growth threatens the environment and mental health.

AI-driven job loss threatens mental health, highlighting the need for societal responses that recognize work's vital role.

Explore insights on bipolar disorder, including suicide risk assessment and comorbidities. Share your insights and experiences today with our February theme!

Exploring the intersection of death, dying, and mental health, this article highlights the importance of discussing mortality for a fulfilling life.

Research reveals links between gut microbiome composition and cognitive decline in Alzheimer disease and mild cognitive impairment.

Authors highlight the importance of recognizing asexuality, promoting inclusive mental health practices for the asexual community.

Check out the pipeline updates from January!

Discover insights from Lauren Kenworthy, PhD on treating comorbid ADHD and autism.

Explore the psychological impacts of the Doomsday Clock, highlighting its correlation with mental health and societal threats in today's world.

John Miller, MD, discusses the APA's new publications on the future of the DSM, highlighting key domains for mental health diagnosis and treatment.

Explore the complex barriers affecting treatment retention for opioid use disorder, highlighting psychological, socioeconomic, and systemic challenges faced by patients.

Along with a new name, the new edition aims to address concerns and critiques of past DSM editions.

Meta-analysis reveals benefit of anti-inflammatory treatment for depression and anhedonia in individuals with inflammatory phenotype.

Reflecting on Holocaust Remembrance Day, H. Steven Moffic, MD, connects past traumas to present challenges, emphasizing the importance of memory and healing.

The FDA has accepted for priority review an NDA for Otsuka's centanafadine, a novel ADHD treatment.

Explore the evolution of social psychiatry, highlighting key achievements and future directions from the World Association of Social Psychiatry's 60th anniversary.

Neurocrine Biosciences launches a phase 2 trial for NBI-1065890.

Sleep is vital for athlete patients, enhancing performance, mental health, and recovery. Discover effective strategies to optimize sleep for peak athletic success.

Explore the complexities of aging, mental health challenges, and the unique opportunities that come with turning 80 in today's society.

LB Pharmaceuticals initiates a phase 2 trial for LB-102, a promising treatment for bipolar depression, aiming to address unmet needs in mood disorders.

What is new in research on major depressive disorder?

Explore how futures thinking empowers mental health professionals to navigate climate change impacts, fostering resilience and agency in uncertain times.

Explore the gradual dangers of societal issues like climate change and mental health, and learn how early intervention can make a difference.

Physical activity boosts fitness, strength, and mental health in schizophrenia, cutting cardiometabolic risk and symptoms—especially with supervised, personalized programs in care.

Therapeutic drug monitoring revolutionizes psychiatric care, enhancing treatment precision and patient outcomes through real-time data and personalized medicine strategies.

Explore the concept of interdependence in politics and psychiatry, emphasizing connection and cooperation to enhance mental health and societal well-being.

Government funding cuts to mental health and addiction programs create chaos, prompting swift restoration amid widespread concern from advocacy groups. Read the statement from the AFSP here.

In this CME article, explore the groundbreaking role of muscarinic cholinergic receptors in schizophrenia treatment, highlighting innovative therapies like KarXT for improved patient outcomes.